2025 Subject Index
Published in Volume 17, Issue 4 (2025)
#
A
- abnormal uterine bleeding, 185, 402
- Acarbose, 120
- ACTH, 72
- ADCY3 gene, 337
- Adolescence, 185
- adolescent, 3, 12, 26, 66, 176, 318, 402
- Adolescent development, 449
- Adolescents, 68, 307
- adrenal crisis, 1, 80, 93
- Adrenal functions, 44
- Adrenal insufficiency, 1, 93
- Adult endocrinology, 269
- Adult height estimation, 410
- AIRE mutation, 359
- antenatal, 1
- antenatal dexamethasone, 33
- antenatal diagnosis, 33
- Anthropometric data, 458
- APS1, 359
- arrhythmia, 146
- attention deficit disorder with hyperactivity, 449
- attitude in management, 269, 387
- atypia of undetermined significance, 428
- autoimmune thyroid disease, 191
- Automated delivery system, 153
- AVPR2, 91
B
C
- CAH screening, 1
- carcinoid, 352
- cardiometabolic risk, 58, 368
- carob-bean gum thickened formula, 237
- case report, 219, 237
- catch-up growth, 458
- Central adrenal insufficiency, 72
- Central diabetes insipidus, 332
- cervical neck mass, 231
- CFRD, 120
- CGMS, 120
- challenges, 379
- Child and adolescent psychiatry, 477
- child development, 449
- childhood, 1, 468
- Children, 1, 3, 9, 12, 26, 46, 66, 72, 146, 168, 288, 359, 365
- children and adolescents, 458
- clinical care, 307
- clinical management in newborns, 109
- COL2A1 gene, 297
- COL2A1-related disorders, 297
- complications, 60
- congenital adrenal hyperplasia, 1, 3, 12, 23, 33, 54, 60, 211, 488
- congenital hypothyroidism, 237, 242, 263, 387, 449
- constitutional delay of growth and puberty, 410
- consultation-liaison psychiatry, 477
- Continuous glucose monitoring, 17, 161
- contrast induced hypothyroidism., 494
- copy number variation, 436
- Cowden syndrome, 46
- critical illness, 44
- Cushing, 352
- cyberbullying/victimization, 419
- CYP17A1 gene, 211
- cystic fibrosis, 120
D
E
F
G
- gastro-intestinal absorption, 237
- gastroesophageal reflux, 237
- gender, 9
- genetics, 1
- genotype-phenotype, 34
- GLI2 mutation, 109
- glucocorticoid, 93
- glucocorticoid replacement treatment, 12
- glucose sensor, 161
- glycaemic dysregulation, 68
- goiter, 46
- goitre, 191
- gonadal dysfunction, 126
- Gonadal function, 136
- gonadotropin, 136
- growth hormone, 76
- growth retardation, 370
- guideline, 72
H
- haematological abnormalities, 109
- handheld ultrasonography, 256
- Hashimoto’s thyroiditis, 269
- HbA1c level, 176
- Heavy menstrual bleeding, 402
- Hereditary hypophosphatemic rickets with hypercalciuria, 326
- Honeymoon phase, 278
- hospitalization, 26
- hypercalcemia, 126
- hypercalciuria, 326
- hypergonadotropic hypogonadism, 97
- Hyperinsulinism, 115
- hypernatremia, 91
- hyperphagia, 337
- hypoglycaemia, 115
- Hypoglycemia, 226
- hypogonadotropic hypogonadism, 103
- hypoparathyroidism, 359
- hypophosphatemia, 126
- hypopituitarism, 109
- Hypothyroidism, 494
I
K
- keratopathy, 359
L
M
N
- neonatal, 1, 44
- neonatal cerebral magnetic resonance imaging, 109
- neonatal hyperthyrotropinemia, 242
- neonatal manifestation, 109
- Neonatal screening, 488
- neonate, 91
- nephrocalcinosis, 219
- Nephrogenic diabetes insipidus, 91
- neudesin, 263
- neurodevelopmental disorders, 449
- newborn screening, 33, 242
- Newborn thyroid volume, 256
- next-generation sequencing, 436
- nocturnal enuresis, 211
- non-classic congenital adrenal hyperplasia, 12
- Noonan syndrome, 76
- normal puberty variants, 396
- NSD1, 219
- nuclear atypia, 428
O
P
- parental collaboration, 176
- PCOS, 202
- Pediatric, 379
- pediatric endocrinology, 269, 387
- Pediatric thyroid nodules, 428
- pediatrics, 226
- Peters-Plus syndrome, 436
- physician attitudes, 307
- pituitary, 332
- Pituitary stalk interruption syndrome, 109
- POLR3A, 103
- polycystic ovary syndrome, 318
- practice, 379
- predicted adult height, 396
- predictive low glucose suspension, 153
- prevention, 80
- Primary adrenal insufficiency, 66
- Primary mitochondrial disease, 34
- problematic internet use, 419
- psychiatric follow-up, 477
- psychological resilience, 58
- psychosocial development, 54
- PTEN hamartoma tumor syndrome, 46
Q
R
S
- school, 365
- SCL34A1, 219
- SCL34A3 pathogenic variants, 326
- second-tier, 488
- secondary, 72
- self-efficacy, 176
- self-esteem, 419
- sex determining region of Y-chromosome, 87
- sexuality, 54
- short stature, 458
- short-trunk dwarfism, 297
- skeletal muscle mass, 458
- sleep quality, 58
- SMARCAL1, 126
- somatotropin, 370
- sorafenib, 345
- Sotos syndrome, 219
- spermatogenesis, 136
- steroid profiling, 488
- stress, 80
- sudden death, 146
T
- TALDO1, 97
- technology, 17
- testicular DSD, 87
- the Bethesda System for Reporting Thyroid Cytopathology Classification, 428
- THRB gene, 191
- Thyroid dysgenesis, 231
- thyroid fine needle aspiration biopsy, 428
- Thyroid hormones, 191
- thyroid nodules, 46
- thyroid papillary carcinoma, 231
- thyroid ultrasound surveillance, 46
- total testosterone, 318
- tracheal index, 256
- Transaldolase deficiency, 97
- treatment, 76, 80, 237
- treatment adherence, 1
- trend, 9
- Turkish Society for Pediatric Endocrinology and Diabetes, 387
- type 1 diabetes, 17, 26, 278, 288, 379
- type 1 diabetes mellitus, 103
- type 2 collagenopathies, 297
U
- ultrasound, 202


